Evidence map›Paper›PMID 21441446›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection.

Mareike Meythaler, Zichun Wang, Amanda Martinot, Sarah Pryputniewicz, Melissa Kasheta, Harold M McClure, Shawn P O'Neil, Amitinder Kaur

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. HIV-associated chronic immune activation.Immunological reviews · 2013
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Natural SIV hosts: showing AIDS the door.Science (New York, N.Y.) · 2012
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mareike MeythalerDepartment of Immunology, New England Primate Research Center, Harvard Medical School, Southborough, MA 01772, USA.
Zichun Wang
Amanda Martinot
Sarah Pryputniewicz
Melissa Kasheta
Harold M McClure
Shawn P O'Neil
Amitinder Kaur
Harvard University · USNew England Biolabs (United States) · USEmory University · US

Funding

ZETA CHAIN OF T CELL RECEPTOR INTERACTS W/ NEF OF SIV &HIV2P51RR000168 · NCRR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WESTMORELAND, SUSAN V. · 1985 to 2011
$139.3M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Immune Responses and Protection in Rhesus MacaquesP01AI046006 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KNIPE, DAVID M. · 1999 to 2010
$11.1M
RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIESR24RR016001 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI REIMANN, KEITH A. · 2000 to 2011
$8.1M
HIGH RESOLUTION STRUCTURAL STUDY OF DSDNA BACTERIOPHAGER01AI040101 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI JOHNSON, JOHN EMIL · 1996 to 2014
$5.2M
Modulation of the early host response to SIV in pathogenic infectionR01AI084810 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI KAUR, AMITINDER · 2009 to 2013
$3.7M
Cell immune responses in SIV-infected sooty mangabeysR01AI049809 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KAUR, AMITINDER · 2001 to 2004
$1.1M
MOUSE MODELS OF CANCER, BONE DISEASE, AND LACTATIONK26RR000168 · NCRR · OHIO STATE UNIVERSITY · PI ROSOL, THOMAS J · 2000 to 2004
$547k
NCRR NIH HHS K26 RR000168NCRR NIH HHS P51 RR000165NCRR NIH HHS P51 RR000168NCRR NIH HHS R24 RR016001NCRR NIH HHS RR00165NCRR NIH HHS RR00168NIAID NIH HHS AI46006NIAID NIH HHS AI49809NIAID NIH HHS N01 AI040101NIAID NIH HHS P01 AI046006NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI50409NIAID NIH HHS R01 AI049809NIAID NIH HHS R01 AI084810
6 · The paper itself

Abstract

Although the cellular immune response is essential for controlling SIV replication in Asian macaques, its role in maintaining nonpathogenic SIV infection in natural hosts such as sooty mangabeys (SM) remains to be defined. We have previously shown that similar to rhesus macaques (RM), SM are able to mount a T lymphocyte response against SIV infection. To investigate early control of SIV replication in natural hosts, we performed a detailed characterization of SIV-specific cellular immunity and viral control in the first 6 mo following SIV infection in SM. Detection of the initial SIV-specific IFN-γ ELISPOT response in SIVsmE041-infected SM coincided temporally with a decline in peak plasma viremia and was similar in magnitude, specificity, and breadth to SIVsmE041-infected and SIVmac239-infected RM. Despite these similarities, SM showed a greater reduction in postpeak plasma viremia and a more rapid disappearance of productively SIV-infected cells from the lymph node compared with SIVmac239-infected RM. The early Gag-specific CD8(+) T lymphocyte response was significantly more polyfunctional in SM compared with RM, and granzyme B-positive CD8(+) T lymphocytes were present at significantly higher frequencies in SM even prior to SIV infection. These findings suggest that the early SIV-specific T cell response may be an important determinant of lymphoid tissue viral clearance and absence of lymph node immunopathology in natural hosts of SIV infection.

Indexed as

AnimalsCD8-Positive T-LymphocytesCell SeparationCercocebus atysFlow CytometryIn Situ HybridizationLymph NodesRNA, ViralSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViremiaRNA, Viral

Identifiers

PMID21441446
PMCPMC3130630
OpenAlexW1515427793

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.